T Cell Responses to Varicella Zoster Virus After Vaccination and Viral Escape

Trial Profile

T Cell Responses to Varicella Zoster Virus After Vaccination and Viral Escape

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Apr 2017

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Varicella zoster virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Jan 2017 Time frame of primary endpoint has been changed from Day 0 to Day 28 to Day 0 to Day 35. primary end point and treatment also amended.
    • 11 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 22 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top